The Pistoia Alliance, a global, not-for-profit alliance that advocates for greater collaboration in life sciences R&D, is announcing the launch of a new project on the microbiome, which could help speed up the advancement of new, precision medicines and treatments. The project – funded by Bayer, BMS, Eagle Genomics, Pfizer, Roche and Takeda – aims to incorporate microbiome data into the drug development pipeline by gathering all existing microbiome data to create a global standardized ‘atlas’ that scientists can refer to when choosing new drug candidates...
Reduced transfer steps and fast pipetting for bacteriocin testing. Researchers at NOMAD Bioscience GmbH, a German R&D company specializing in plant biotechnology, are taking advantage of the remarkable liquid handling capabilities of INTEGRA’s VOYAGER adjustable tip spacing pipette for the preparation and dispensing of media and gels. Research scientist Birgit Koch explained how she uses the VOYAGER in her work...
Beckman Coulter Life Sciences continues to work with chemistry companies seeking collaborations to develop applications for the Biomek NGeniuS Next Generation Library Preparation System ahead of its launch. An application development agreement has been signed with Illumina, a developer of solutions for the sequencing and analysis of genomes, to develop new applications on the Biomek NGeniuS System...
As part of a mutual objective to safeguard high and consistent liquid handler performance levels, Hamilton Company and Artel have announced that they are near completion of a packaged solution to standardize performance validation of Hamilton’s automated liquid handlers. This packaged solution will reduce time and efforts compared to assay-specific validation methods, ensure highly consistent, accurate, and precise results, and strengthen the ability to compare performance...
Thermo Fisher Scientific, the world leader in serving science, and Symphogen, an affiliate of and the antibody center of excellence within the international pharmaceutical company Servier, announce the continuation of their collaboration to provide biopharmaceutical discovery and development laboratories with innovative tools and streamlined workflows for efficient characterization of complex therapeutic proteins...
Agilent Technologies Inc. (NYSE: A) and the University of Vermont (UVM) have announced the establishment of the Agilent Laboratory for Chemical Analysis (ALCA). The facility will be a hub for advanced instrumentation that will allow students, institutional colleagues, industrial partners, and regional high-tech start-ups to study the composition and structure of chemical samples....
Scitara, proven innovator in laboratory digital transformation, announces it has become a member of BioPhorum, a global community that enables collaboration throughout the biopharmaceutical industry with the goal of accelerating scientific advancements. Scitara joins BioPhorum Information Technology, whose mission is to accelerate digital maturity across the global biomanufacturing industry...
As part of its continuing commitment to laboratory informatics education for laboratory personnel worldwide, Autoscribe Informatics has made available a recent webinar entitled “Justifying the Purchase of a LIMS.” Ideal for laboratory professionals purchasing or upgrading a Laboratory Information Management System (LIMS) it is especially useful for those about to embark for the first time on the journey of selecting a LIMS for their laboratory.
Dyad Medical, Inc., the developer of the cloud-based AI technology for cardiac image analysis called LibbyTM, announced that the U.S. Food and Drug Administration (FDA) has cleared LibbyTM IAAA through the 510(k) pathway. LibbyTM IAAA offers image analysis used for viewing and quantifying Intravascular Optical Coherence Tomography (IVOCT) images.
World first: Human Cell Design has developed maturation process to obtain unlimited quantity of functional human cellssimilar in every respect to native human cells. Human Cell Design (formerly Univercell-Biosolutions), a biotechnology company focused on generating translational human cellular models, announces the launch of Endoc-BH5®, the fifth version of its model of ready-to-use, > 99% pure population of functional human pancreatic beta cells available in unlimited quantities...
ZEISS recently caught up with the team from the Mostowy Lab at the London School of Hygiene & Tropical Medicine, UK. Watch the video below to hear how their ZEISS Celldiscoverer 7 has transformed the way they carry out research across the entire lab - from streamlining workflows to standardising results. ZEISS Celldiscoverer 7 is your automated microscope for live cell imaging, combining the ease-of-use of an automated high-end imaging system with the image quality and flexibility of a classic inverted research microscope...
INTEGRA Biosciences has reported considerable growth for over 10 years – averaging 18 percent per annum – and more than doubling in the previous two years. The company grew by 73 percent in 2020, and has followed this with a 46 percent increase in turnover in 2021, reaching 191 million Swiss Francs. The life sciences industry is thriving, and there is currently unprecedented demand for liquid handling solutions...
The Scientific Laboratory Show and Conference is back! The event will take place on 18th of May 2022 hosted and organised by Scientific Laboratory Supplies (SLS) – the UK's largest independent supplier of chemicals, laboratory equipment and consumables. Working in partnership with the Science Council, the show is FREE to attend at the East Midlands Conference Centre in Nottingham with doors opening at 9.00am and closing at 5.00pm...
The research neutron source Hein Maier-Leibnitz (FRM II) at the Technical University of Munich (TUM) is playing an important role in the investigation of mRNA nanoparticles similar to the ones used in the Covid-19 vaccines from vendors BioNTech and Pfizer. Researchers at the Heinz Maier-Leibnitz Zentrum (MLZ) used the high neutron flux available in Garching to characterize various formulations for the mRNA vaccine and thus to lay the groundwork for improving the vaccine's efficacy...
Asynt reports how AM Technology Ltd (Runcorn, UK) has used its ReactoMate ATOM lab reactor support stand to enhance the speed and ease of switching reaction vessels feeding their Coflore® flow chemistry system. Martin Monedero, principal chemist at AMT, commented "Our Coflore flow systems are designed to be as versatile as possible, enabling users to optimise feed vessel set up according to the requirements of a particular reaction. For users to be able to swap reaction vessels quickly and easily is a significant benefit...
Biobanking is a critical facility in many drug discovery, pathology, and personalized medicine organisations. It enables researchers to effectively manage biological sample collections in an easily accessible repository. Unfortunately, while smaller biobanks and biorepositories still need to select tubes from cold racks straight from the freezer, they cannot necessarily afford the significant investment in robotics to fully automate the picking and placing of sample storage tubes from racks..
Microtrac MRB and Colloid Metrix GmbH announce that effective February 15th, 2022 Microtrac MRB has acquired the STABINO™ product line from Colloid Metrix. Microtrac MRB is a leading provider of particle characterization technologies and part of the Scientific Division of the international Verder Group. The STABINO™ has been established as a worldwide standard for the measurement of zeta potential and stability in suspensions and emulsions for many years.
Coriolis Pharma, a globally operating service provider and one of the world leaders in formulation research and development of biopharmaceuticals and vaccines, has announced the opening of its new ATMP development facilities under biosafety level S2 (BSL2 / S2). After one year of re-construction, the new facilities in close proximity to Coriolis’ headquarters in Martinsried will significantly increase Coriolis’ capabilites for ATMP development....
Nuclera, a biotech company developing cutting-edge benchtop protein printing technologies, today announced that the first close of its Series B financing has raised $42.5 million. The funds raised will be used to accelerate the development and commercialization of its eProtein™ desktop bioprinter. Nuclera’s ground-breaking protein printing technology has attracted many new and existing institutional and strategic investors...
In December 2021, ZEISS entered a strategic partnership with the Kennedy Institute of Rheumatology (KIR) and the Institute of Developmental and Regenerative Medicine (IDRM), developing the Oxford-ZEISS Centre of Excellence (Oxford-ZCoE). The Kennedy Institute of Rheumatology (KIR) is a world-leading medical research centre where discovery research drives development of transformative therapies for chronic inflammatory and degenerative disease....
A first of its kind, mobile platform for cell and gene therapy was introduced by Germfree Labs, a Florida company, at Advanced Therapies Week in Miami Beach. The new bioGO® cGMP Mobile Cleanroom solves complex logistical challenges facing the CGT (cell and gene therapy) industry. The flexible bioprocessing platform was designed by Germfree in response to critical constraints in the development, manufacturing and delivery of new and emerging curative therapies...
Asynt reports how the Process Intensification Group, within the School of Engineering at Newcastle University, UK is using the MultiCell-PLUS High-Pressure Reactor as part of their program of ongoing research to create a new environmentally friendly generation of catalysts for production of biorenewable chemicals. Many industrial processes rely on catalysts containing expensive precious and metals, or metals sourced from areas of conflict...